EP3454835
LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.5.2017EP published:
31.3.2021EP application number:
17721707.2
EPO information:
European Patent Register
Max expiry date:
7.5.2037
Title:
LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF
Timeline
Today
8.5.2017EP application
31.3.2021EP Publication
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
LINDFORS, LennartAddress:
SE-431 83 Molndal, SE
Name:
KJELLMAN, TomasAddress:
SE-431 83 Molndal, SE
Priority
Number:
201662333574 PDate:
9.5.2016Country:
US
Number:
201662359429 PDate:
7.7.2016Country:
US
Number:
201762449623 PDate:
24.1.2017Country:
US
Classification
Categories:
A61K 9/127, A61K 45/06, A61K 48/00, A61K 9/51, A61K 31/58